These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31219164)

  • 1. What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors.
    Oliver D; Reilly TJ; Baccaredda Boy O; Petros N; Davies C; Borgwardt S; McGuire P; Fusar-Poli P
    Schizophr Bull; 2020 Jan; 46(1):110-120. PubMed ID: 31219164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiglucocorticoid and related treatments for psychosis.
    Garner B; Phillips LJ; Bendall S; Hetrick SE
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD006995. PubMed ID: 26725721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis.
    Davies C; Radua J; Cipriani A; Stahl D; Provenzani U; McGuire P; Fusar-Poli P
    Front Psychiatry; 2018; 9():187. PubMed ID: 29946270
    [No Abstract]   [Full Text] [Related]  

  • 5. What causes psychosis? An umbrella review of risk and protective factors.
    Radua J; Ramella-Cravaro V; Ioannidis JPA; Reichenberg A; Phiphopthatsanee N; Amir T; Yenn Thoo H; Oliver D; Davies C; Morgan C; McGuire P; Murray RM; Fusar-Poli P
    World Psychiatry; 2018 Feb; 17(1):49-66. PubMed ID: 29352556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
    Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
    JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.
    Yung AR; Phillips LJ; Yuen HP; McGorry PD
    Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.
    Salazar de Pablo G; Radua J; Pereira J; Bonoldi I; Arienti V; Besana F; Soardo L; Cabras A; Fortea L; Catalan A; Vaquerizo-Serrano J; Coronelli F; Kaur S; Da Silva J; Shin JI; Solmi M; Brondino N; Politi P; McGuire P; Fusar-Poli P
    JAMA Psychiatry; 2021 Sep; 78(9):970-978. PubMed ID: 34259821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas.
    Arango C; Dragioti E; Solmi M; Cortese S; Domschke K; Murray RM; Jones PB; Uher R; Carvalho AF; Reichenberg A; Shin JI; Andreassen OA; Correll CU; Fusar-Poli P
    World Psychiatry; 2021 Oct; 20(3):417-436. PubMed ID: 34505386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis.
    Salazar de Pablo G; Davies C; de Diego H; Solmi M; Shin JI; Carvalho AF; Radua J; Fusar-Poli P
    Eur Psychiatry; 2021 Jul; 64(1):e51. PubMed ID: 34315555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions and social functioning in youth at risk of psychosis: A systematic review and meta-analysis.
    Devoe DJ; Farris MS; Townes P; Addington J
    Early Interv Psychiatry; 2019 Apr; 13(2):169-180. PubMed ID: 29938910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis as a risk factor for psychosis: systematic review.
    Semple DM; McIntosh AM; Lawrie SM
    J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What makes the psychosis 'clinical high risk' state risky: psychosis itself or the co-presence of a non-psychotic disorder?
    Hasmi L; Pries LK; Ten Have M; de Graaf R; van Dorsselaer S; Bak M; Kenis G; Richards A; Lin BD; O'Donovan MC; Luykx JJ; Rutten BPF; Guloksuz S; van Os J
    Epidemiol Psychiatr Sci; 2021 Jul; 30():e53. PubMed ID: 34225831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duration of untreated psychosis: A state-of-the-art review and critical analysis].
    Souaiby L; Gaillard R; Krebs MO
    Encephale; 2016 Aug; 42(4):361-6. PubMed ID: 27161262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is acute and transient psychotic disorder (ATPD) mini schizophrenia? The evidence from phenomenology and epidemiology.
    Farooq S
    Psychiatr Danub; 2012 Oct; 24 Suppl 3():S311-5. PubMed ID: 23114808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.